Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
409
-
Total 13F shares, excl. options
-
43.1M
-
Shares change
-
-1.31M
-
Total reported value, excl. options
-
$9.32B
-
Value change
-
-$262M
-
Put/Call ratio
-
0.46
-
Number of buys
-
173
-
Number of sells
-
-214
-
Price
-
$216.08
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q4 2021
485 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q4 2021.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 409 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.1M shares
of 44.8M outstanding shares and own 96.25% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.24M shares), VANGUARD GROUP INC (4.16M shares), Avoro Capital Advisors LLC (3.04M shares), RENAISSANCE TECHNOLOGIES LLC (2.92M shares), FMR LLC (2.52M shares), STATE STREET CORP (1.52M shares), Bank of New York Mellon Corp (1.01M shares), WELLINGTON MANAGEMENT GROUP LLP (965K shares), GEODE CAPITAL MANAGEMENT, LLC (761K shares), and FULLER & THALER ASSET MANAGEMENT, INC. (731K shares).
This table shows the top 409 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.